The Stanford Medicine Department of Medicine is excited to welcome three faculty members to its Division of Oncology: Curtis Chong, MD, PhD; Fauzia Riaz, MD; and Shagufta Shaheen, MD. Each of these individuals brings an impressive record of academic pursuits focused on advancing care for and treatment of this disease.
Curtis Chong, MD, PhD
Fauzia Riaz, MD
Shagufta Shaheen, MD
Dr. Chong is Clinical Assistant Professor of Oncology. He will work in the clinician educator line with the Phase I Group and will also act as a general medical oncologist in the UHA Group in Redwood City. Prior to joining Stanford, Dr. Chong worked at Memorial Sloan Kettering Cancer Center, where he was an active participant in its Phase I Program. He completed a fellowship in hematology/oncology at Dana-Farber Cancer Institute in 2015.
Dr. Riaz is Clinical Assistant Professor specializing in breast oncology. With a strong interest in palliative care, Dr. Riaz will work in the Women’s Cancer Center in both patient care and clinical research. She joins Stanford from Yale, where she trained as a hematology/oncology fellow this past year. She completed an internal medicine residency at Georgetown and also served as Chief Resident of the program.
Dr. Shaheen joins as Clinical Assistant Professor and will split her outpatient clinic time between the GI group and neuroendocrine group as well as support the Department’s inpatient oncology work. She may be a familiar face on campus having recently completed advanced fellowship training in neuroendocrine tumors at Stanford. Dr. Shaheen trained as a hematology/oncology fellow at Loma Linda and also served as a hospitalist at Massachusetts General Hospital. ■
